VIP · Research brief

VIP Price: What Research-Grade VIP Peptide Costs

Real Peptides Research TeamEditorial

Updated September 16, 20268 min read

58 WORDS

Short answer

The VIP price on any listing is set by chemistry, not by hype. Vasoactive intestinal peptide runs 28 amino acids long, which means roughly 27 sequential coupling reactions in solid-phase peptide synthesis. Even at a strong 99% efficiency per coupling, the arithmetic caps theoretical crude yield near 76% before purification throws more away. Tripeptides don't carry that penalty.

Key takeaways

VIP price is driven by chain length: vasoactive intestinal peptide is 28 amino acids with a C-terminal amide, requiring roughly 27 coupling steps and Rink amide resin chemistry.
At 99% efficiency per coupling across 27 couplings, theoretical crude yield caps near 76%, which is why long peptides cost more per milligram than tripeptides.
Compare cost per milligram of net peptide content rather than per vial, because counterion salt and residual water sit inside the labelled fill weight.
A certificate of analysis whose lot number matches your vial is the only auditable part of any VIP price, and an undated certificate is not evidence.
Lyophilised VIP is stored near minus 20°C, reconstituted material belongs at 2°C to 8°C, and freeze-thaw cycles degrade peptide integrity regardless of what you paid.
VIP sold for laboratory research is not an approved drug and is not for human or veterinary use, so pricing analysis never substitutes for your own regulatory compliance.

Our team runs small-batch synthesis with exact sequencing on every lot, and we've watched buyers treat a low VIP price as a win. It almost always signals a missing line item rather than a genuine discount.

What is the VIP price for research-grade vasoactive intestinal peptide?

VIP price is quoted per vial rather than per milligram, and it sits above short-chain research peptides because vasoactive intestinal peptide is 28 residues long with an amidated C-terminus. Cost tracks purity documentation, net peptide content and cold-chain shipping. Compare listings by milligram of actual peptide, never by the headline vial figure.

The common oversimplification is that VIP price is a single market number you can benchmark against. It isn't. Two vials both labelled 5mg can hold meaningfully different amounts of peptide once you subtract counterion salt and residual water, so the real VIP price is what you paid divided by net peptide content. What follows covers the manufacturing drivers behind the cost, the documents that justify it, and how to compare two listings without guessing.

What actually drives the cost of a VIP vial

Chain length is the dominant cost driver, and it compounds at every stage of manufacturing. Each residue added in solid-phase peptide synthesis (SPPS) means another coupling, another deprotection, and another opportunity for a deletion sequence to form. Vasoactive intestinal peptide carries 28 residues plus a C-terminal amide, so production needs Rink amide resin and a separate analytical confirmation that the amide is actually present. Hydrophobic stretches mid-chain encourage on-resin aggregation, which chemists counter with double couplings or pseudoproline dipeptides. Every one of those interventions costs reagent, time and yield, and all of it lands in the VIP price.

VIP itself was first isolated in 1970 from porcine duodenum and signals through the VPAC1 and VPAC2 receptors, class B G protein-coupled receptors that raise intracellular cAMP. None of that biology sets the cost. The synthesis does.

Purification is the second driver. Crude material runs through reverse-phase HPLC, and every pass that lifts purity toward 98% or better discards usable peptide. Then come identity confirmation by mass spectrometry against an average mass near 3.3 kilodaltons, water content testing, and net peptide content determination.

Batch size finishes the picture. Small-batch synthesis raises cost per milligram but stops one out-of-spec run from contaminating months of inventory. We've declined cheaper bulk routes for exactly that reason, and it's the part of the VIP price buyers never see on the listing.

The paperwork that justifies what you pay

A batch-specific certificate of analysis is the only part of a VIP price you can independently audit. A usable certificate shows the lot number, the HPLC chromatogram with retention time and integrated purity, a mass spectrometry trace confirming identity, the analysis date, and net peptide content. Miss any of those and you're buying a label, not a characterised compound.

Here's the failure mode most buying guides skip entirely. The problem is rarely a forged certificate. It's a genuine certificate from a different batch. A reseller receives one document with a first shipment from a contract manufacturer, then attaches that same PDF to every order for the next year. The chemistry on the page is real. It simply doesn't describe the vial in your hand. Match the lot number printed on the vial to the lot number on the certificate before you look at anything else. If the document carries no lot and no date, treat the VIP price as unsupported by evidence.

Third-party testing is the other line item worth paying for, because an independent laboratory has no commercial reason to round a purity figure upward. In our experience, the gap between a suspiciously cheap listing and a fully documented one is almost always this single step, and it stays invisible until an assay behaves strangely.

How to compare two listings before you commit

Run the per-milligram arithmetic, because vial fill weight is where headline figures mislead. Divide total landed cost, meaning vial plus shipping plus any cold-pack surcharge, by the net peptide content stated on the certificate rather than the gross weight printed on the label. Net peptide content subtracts counterion salt, usually trifluoroacetate left behind by HPLC purification, along with residual water from lyophilisation. On a 28-residue peptide, that difference is not a rounding error.

So which listing is actually cheaper? Frequently the higher one. Larger vial fills usually lower per-milligram cost because fixed costs, meaning synthesis setup, quality control, lyophilisation and labelling, spread across more material. Whether that helps depends entirely on throughput. Lyophilised VIP is held at roughly minus 20°C, while reconstituted solution belongs at 2°C to 8°C and degrades far faster, and repeated freeze-thaw cycles damage peptide integrity. Buying a large vial you can't consume before it degrades costs more than the VIP price suggested on screen.

One compliance point, stated plainly. VIP supplied for laboratory research is not an FDA-approved drug, is not for human or veterinary consumption, and nothing here is dosing, administration or protocol guidance. If your question concerns an animal, talk to your veterinarian rather than a peptide supplier. Research use means research use, and serious suppliers document that boundary as carefully as they document purity.

VIP price versus shorter peptides: a chain-length comparison

Chain length maps almost directly onto relative cost across any catalogue. The table below shows where VIP sits against commonly researched peptides on the factors that genuinely set price.

Compound	Approximate chain length	Synthesis and purification burden	Relative per-mg cost tier	Bottom line
GHK-Cu	3 amino acids plus copper complex	Short synthesis, though copper complexation adds a controlled step and its own QC	Low	Cheap to produce; supplier price gaps usually reflect complexation quality, not chain difficulty.
Ipamorelin	5 amino acids	Straightforward SPPS, few problem residues, fast purification	Low	Short-chain economics mean an unusually high listing reflects margin, not chemistry.
BPC-157	15 amino acids	Moderate coupling count, generally well-behaved sequence	Moderate	A fair midpoint benchmark for judging whether a supplier prices by chemistry or by guesswork.
Tesamorelin	44 amino acids	Long chain, aggregation-prone, heavy purification losses	High	Longer than VIP; priced near a tripeptide, the documentation deserves scrutiny.
VIP (vasoactive intestinal peptide)	28 amino acids with C-terminal amide	Around 27 couplings, amide resin, multiple HPLC passes, higher analytical load	High	VIP price should sit clearly above mid-length peptides, and a bargain figure is the loudest warning on the page.

What If: VIP Sourcing Scenarios

What if one listing costs half of every other supplier?

Request the batch-specific certificate before ordering anything. Genuine cost advantages in peptide manufacturing come from scale and yield, and both produce modest differences, not halved figures. A halved VIP price usually means one of three things: a shorter or incorrect sequence, a purity claim with no chromatogram behind it, or documentation recycled from an older lot. Verify the lot first, then compare numbers.

What if the vial arrives warm or the cold pack has melted?

Photograph the packaging condition on arrival and contact the supplier before opening the vial. Lyophilised VIP tolerates short ambient excursions better than reconstituted solution does, but tolerance isn't immunity, and degradation doesn't change how a white powder looks. If chain integrity matters to the assay, replacement is the defensible decision rather than optimism.

What if the certificate has no lot number on it?

Treat the material as undocumented until the supplier sends the matching document. A certificate without a lot number and an analysis date can't be tied to the vial you received, which turns the purity figure into a marketing claim rather than a measurement. Suppliers running proper quality control publish per-lot certificates and can retrieve yours quickly.

What if your own HPLC shows a peak the supplier's chromatogram doesn't?

Compare method conditions before assuming contamination. Column chemistry, gradient profile, flow rate and detection wavelength all change what a chromatogram looks like, so an unexpected peak can be a method artefact or a counterion-related signal. If conditions genuinely match and the peak persists, ask for a retain sample from the same lot for independent testing.

The Unglamorous Truth About Cheap Peptide Listings

Here's the honest answer: below a certain point, a low VIP price isn't a discount, it's a deleted line item. Purity testing, mass spectrometry, third-party verification, cold-chain packaging and small-batch synthesis all cost real money, and a supplier undercutting the market by half has removed at least one of them. Nobody advertises which one. The experiment that fails six months later costs far more than the money saved, and you won't be able to prove the peptide caused it.

Current vial options and the live VIP price sit on the VIP product page, batch certificates for every lot are published on our certificates of analysis page, the wider research catalogue is in the shop, and facility and shipping details are listed on our location page.

The most expensive VIP price is the one attached to material you can't verify. Peptide research fails quietly: no alarm, no recall, just results that refuse to replicate and a year spent chasing a variable nobody suspected. A 28-residue amidated neuropeptide has more ways to go wrong during synthesis than a tripeptide has ways to exist at all. Price it accordingly, read the chromatogram, match the lot number. The chemistry doesn't negotiate.

References

Peer-reviewed sources on VIP (Vasoactive Intestinal Peptide) indexed in PubMed, listed for research context. Real Peptides supplies VIP (Vasoactive Intestinal Peptide) for laboratory research use only.

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature. AACE clinical case reports, 2022. PMID 35959082. doi:10.1016/j.aace.2022.03.003
Vasoactive Intestinal Peptide-Secreting Tumors: A Review. Pancreas, 2019. PMID 31609932. doi:10.1097/MPA.0000000000001402
Neuronal VIP shapes intestinal stem cell activity and mucosal immunity. Cell stem cell, 2026. PMID 41795422. doi:10.1016/j.stem.2026.02.001
Nanoparticle-Driven Tendon Repair: Role of Vasoactive Intestinal Peptide in Immune Modulation and Stem Cell Enhancement. ACS nano, 2025. PMID 40184556. doi:10.1021/acsnano.4c16917
Contribution of Vasoactive Intestinal Peptide to the Depressant Effects of Glucagon-like Peptide-2 on Neurally Induced Contractile Responses in Mouse Ileal Preparations. International journal of molecular sciences, 2025. PMID 41465229. doi:10.3390/ijms262411797
Vasoactive Intestinal Peptide: A Neuropeptide that Plays an Important Role in Parkinson's Disease. Current neuropharmacology, 2025. PMID 40353414. doi:10.2174/011570159X374501250425045109
Suprachiasmatic Nucleus Vasoactive Intestinal Peptide Neurons Mediate Light-induced Transient Forgetting. Neuroscience bulletin, 2025. PMID 40670769. doi:10.1007/s12264-025-01456-7
Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma. Journal of Indian Association of Pediatric Surgeons, 2024. PMID 39691933. doi:10.4103/jiaps.jiaps_104_24

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Divide the total landed cost, meaning the vial plus shipping and any cold-chain surcharge, by the net peptide content listed on the certificate of analysis rather than the gross fill weight on the label. Net peptide content excludes counterion salt such as trifluoroacetate and residual water from lyophilisation, so gross weight always overstates how much peptide you actually received. On a 28-residue peptide like VIP, that gap is large enough to flip which of two listings is genuinely cheaper.

Most of the variation comes from what a supplier does after synthesis rather than the synthesis itself. Additional reverse-phase HPLC purification passes, mass spectrometry identity confirmation, third-party purity testing, net peptide content determination and cold-chain packaging are all optional costs a seller can quietly skip. Two listings with identical labels can therefore represent very different levels of characterisation, which is why the lot-matched certificate matters more than the headline figure.

Research-grade vasoactive intestinal peptide is supplied to researchers, laboratories and institutions for in-vitro and laboratory research use only. It is not an FDA-approved drug product and is not sold for human or veterinary consumption. Buyers are responsible for compliance with their own institutional, state and federal requirements covering the handling and storage of research chemicals.

The practical risk is an unidentified variable inside your data. Without a lot-matched certificate showing an HPLC chromatogram and a mass spectrometry trace, you cannot rule out deletion sequences, incorrect amidation, elevated residual solvent, or a shorter peptide sold under the VIP label. Those defects don't change how the lyophilised powder looks, so the problem typically surfaces as results that fail to replicate months later.

Generally yes, and the reason is chain length. GHK-Cu is a tripeptide and BPC-157 is a 15-amino-acid pentadecapeptide, while VIP runs 28 residues with a C-terminal amide requiring Rink amide resin and an extra analytical confirmation step. More couplings mean lower crude yield, heavier purification losses and a higher analytical burden, all of which raise per-milligram cost.

VIP terminates in an amide rather than a free carboxylic acid, which means synthesis must start on an amide-forming resin such as Rink amide rather than standard Wang resin. That resin is more expensive, and the finished product needs an additional analytical step confirming the amide is present, since a peptide missing it has a different mass and different receptor behaviour. Those two requirements are part of why VIP sits in a higher price tier than a same-length acid-terminated peptide.

Net peptide content is the percentage of the vial contents that is actually peptide, with counterion salt and bound water subtracted out. Peptides purified by reverse-phase HPLC typically retain trifluoroacetate counterions, and lyophilised powder holds residual moisture, so a vial labelled 5mg by gross weight contains less than 5mg of peptide. Comparing suppliers on gross weight alone is the single most common pricing error.

Lyophilised vasoactive intestinal peptide is generally stored at around minus 20°C, protected from light and moisture, with the vial kept sealed until use. Once reconstituted, solutions are held refrigerated at 2°C to 8°C and are substantially less stable than the dry powder. Aliquoting before freezing avoids repeated freeze-thaw cycles, which degrade peptide integrity without any visible change to the sample.

Usually, yes, because each additional HPLC purification pass that lifts purity discards recoverable material and adds labour. A listing specifying 95% purity is cheaper to produce than one specifying 98% or higher. The problem is that many low-cost listings state no purity figure at all, or state one with no chromatogram attached, which is not the same thing as a lower specification honestly disclosed.

Yes, and asking for one is the fastest way to separate serious suppliers from resellers. A batch-specific certificate carries the lot number, analysis date, HPLC purity with the chromatogram, and mass spectrometry identity data for the exact material being shipped. Real Peptides publishes per-lot certificates for catalogue compounds, and any supplier who can only send a generic or undated document should be treated with caution.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA